Total: $180.3 million

Top 2 drugs
Humira (arthritis): $62 million; Humira (psoriasis): $36.7 million
Androgel: $45.6 million
Watch the Humira TV commercial here >>

One might wonder why a company that has the best-selling drug in the world--and one that is slated to remain the best-selling drug for the next 5 years--would feel the need to spend money advertising it. The reason is that until AbbVie ($ABBV) can push some new drugs out of its pipeline, the company will rise, or fall, on sales of the arthritis drug. Humira generated $9.6 billion in global revenues last year. The advertising must be helping because U.S. sales were up 19% to $2.18 billion in the first half of 2013.


Suggested Articles

Drug pricing remains the pharma industry's top concern in 2020, execs said in a survey, as political threats continue from Washington, D.C.

Allergan updated its Botox marketing for chronic migraine by featuring strong women powering through their too-frequent migraine days.

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.